Clinical Trial

Intrathecal Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells for Children With Cerebral Palsy

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-center, open-label, single-arm Phase I pilot study designed to evaluate the feasibility and short-term safety of a single intrathecal administration of allogeneic umbilical cord tissue-derived mesenchymal stromal cells (UCT-MSCs) in children with cerebral palsy (CP).
Trial Details
NCT Number NCT07763028
Lead Sponsor Gadjah Mada University
Conditions Cerebral Palsy (CP)
Enrollment 7 participants
Start Date 2024-12-01
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-13